Mike Alls
Analyst
Morgan Stanley
Equibles does not estimate personal net worth.
About Mike Alls
Mike Alls is recorded as Analyst at Morgan Stanley. Mike Alls has spoken on 2 earnings calls across 2 companies, most recently for Rhythm Pharmaceuticals, Inc. on August 4, 2026. Those appearances were for Rhythm Pharmaceuticals, Inc. (RYTM) and Alnylam Pharmaceuticals, Inc. (ALNY). The companies whose calls Mike Alls spoke on are classified in the Healthcare sector.
Mike Alls on recent calls
“Thanks for taking the question, and congratulations on the strong quarter and 718 data as well.”
“And maybe just to follow up on the generic TAF question, would you anticipate increased combo use in the frontline setting, or would that be more of a second-line setting effect?”
Affiliation history
-
Morgan Stanley
Analyst
Transcript header (unverified)
Current